Assessing Risk of Maternal Death in Pregnancies Complicated by Cancer - For The Media

JAMA Oncology

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 16, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1795?guestAccessKey=53666fe6-8c61-4ef6-8aa1-925d724bbda0&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=061622

About The Study: Researchers examined nationwide trends and characteristics of severe adverse health conditions, outcomes and death among pregnant women with cancer in the United States.

Authors: Koji Matsuo, M.D., Ph.D., of the University of Southern California in Los Angeles, is the corresponding author.

(doi:10.1001/jamaoncol.2022.1795)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.